Show simple item record

dc.contributor.authorGomes, Fabio
dc.contributor.authorYip, K
dc.contributor.authorBlackhall, Fiona H
dc.contributor.authorGreystoke, A
dc.contributor.authorCalifano, Raffaele
dc.contributor.authorGhosh, S
dc.contributor.authorNewsom-Davis, T
dc.contributor.authorMills, H
dc.contributor.authorAhmed, S
dc.contributor.authorHarle, A
dc.contributor.authorSummers, Yvonne J
dc.date.accessioned2019-02-08T15:20:07Z
dc.date.available2019-02-08T15:20:07Z
dc.date.issued2018en
dc.identifier.citationGomes F, Yip K, Blackhall F, Greystoke A, Califano R, Ghosh S, et al. P2.13-01 Brigatinib use in England - where next? J Thorac Oncol. 2018;13(10):S798.en
dc.identifier.doi10.1016/j.jtho.2018.08.1396en
dc.identifier.urihttp://hdl.handle.net/10541/621517
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1016/j.jtho.2018.08.1396en
dc.titleBrigatinib use in England - where next?en
dc.typeMeetings and Proceedingsen
dc.contributor.departmentThe Christie NHS Foundation Trust, Manchester, UKen
dc.identifier.journalJournal of Thoracic Oncologyen
dc.description.noteen]


Files in this item

This item appears in the following Collection(s)

Show simple item record